Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 (2020)
Attributed to:
Translating potent SARS-Cov-2 neutralising nanobodies from the lab to the clinic
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41594-020-0469-6
PubMed Identifier: 32661423
Publication URI: http://europepmc.org/abstract/MED/32661423
Type: Journal Article/Review
Parent Publication: Nature Structural & Molecular Biology
Issue: 9
ISSN: 1545-9985